86
Participants
Start Date
February 19, 2021
Primary Completion Date
June 30, 2022
Study Completion Date
June 30, 2022
Tafenoquine Oral Tablet
Patients will be randomized and will receive and self-administer 200 mg Tafenoquine or matching placebo on Days 1, 2, 3, and 10.
Placebo
Patients will be randomized and will receive and self-administer 200 mg Tafenoquine or matching placebo on Days 1, 2, 3, and 10.
Burke Primary Care, Morgantown
AFC Urgent Care, Easley
Deluxe Health Center LLC, Miami
Hope Clinical Trials, Miami
F&T Medical Research, Inc., Miami
Kendall South Medical Center, Inc., Miami
Skyline Medical Center, Elkhorn
Care United, Forney
Clinical Trial Network, Houston
Centex Studies, Brownsville
Lead Sponsor
60 Degrees Pharmaceuticals LLC
INDUSTRY